Evidence map›Paper›PMID 35592652›Full record

ReviewFrontiers in cellular and infection microbiology2022

Circulating Microbiota in Cardiometabolic Disease.

Keiichi Sumida, Zhongji Han, Chi-Yang Chiu, Tahliyah S Mims, Amandeep Bajwa, Ryan T Demmer, Susmita Datta, Csaba P Kovesdy, Joseph F Pierre

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Pathological Alterations in Human Blood Microbiome-An Updated Review.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Keiichi SumidaDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Zhongji HanDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Chi-Yang ChiuDepartment of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Tahliyah S MimsDepartment of Nutritional Sciences, College of Agriculture and Life Science, University of Wisconsin-Madison, Madison, WI, United States.
Amandeep BajwaTransplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, School of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Ryan T DemmerDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States.
Susmita DattaDepartment of Biostatistics, University of Florida, Gainesville, FL, United States.
Csaba P KovesdyDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Joseph F PierreDepartment of Nutritional Sciences, College of Agriculture and Life Science, University of Wisconsin-Madison, Madison, WI, United States.
University of Tennessee Health Science Center · USUniversity of Wisconsin–Madison · USColumbia University · USMemphis VA Medical Center · USUniversity of Florida · US

Funding

The Subgingival Microbiome and Impaired Glucose RegulationR01DK102932 · NIDDK · UNIVERSITY OF MINNESOTA · PI DEMMER, RYAN T. · 2015 to 2019
$3.1M
Role of microbial-modulated bile acid receptor signaling in breast cancerR01CA253329 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Katherine Loree Cook, Liza Makowski-Hayes · 2020 to 2026
$3.0M
Circulating microbiome and premature mortality in hemodialysis patientsR01DK125586 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SUMIDA, KEIICHI · 2020 to 2024
$2.8M
Mitochondrial Therapy for Kidney InjuryR01DK117183 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI BAJWA, AMANDEEP · 2018 to 2022
$1.7M
Modeling Host-Fungal Interactions in Hirschsprung-Associated EnterocolitisR21AI163503 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI GOSAIN, ANKUSH, PIERRE, JOSEPH F · 2021 to 2022
$441k
NCI NIH HHS R01 CA253329NIAID NIH HHS R21 AI163503NIDDK NIH HHS R01 DK102932NIDDK NIH HHS R01 DK117183NIDDK NIH HHS R01 DK125586
6 · The paper itself

Abstract

The rapid expansion of microbiota research has significantly advanced our understanding of the complex interactions between gut microbiota and cardiovascular, metabolic, and renal system regulation. Low-grade chronic inflammation has long been implicated as one of the key mechanisms underlying cardiometabolic disease risk and progression, even before the insights provided by gut microbiota research in the past decade. Microbial translocation into the bloodstream can occur

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Gastrointestinal MicrobiomeMicrobiotaHumansInflammationcardiometabolic diseasecardiovascular diseasechronic kidney diseasecirculating microbiotadiabetes mellitusend-stage kidney diseasegut microbiotainflammation

Identifiers

PMID35592652
PMCPMC9110890
OpenAlexW4225388759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.